Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer
Clinical trial NCT00379015 · COMPLETED
Trial details
- NCT number
- NCT00379015
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2016-03-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.